期刊文献+

血清PA、ALB及TBA联合检测在肝病诊断中的应用价值 被引量:7

Application value of combined detection of serum PA,ALB and TBA in diagnosis of liver disease
下载PDF
导出
摘要 目的探讨血清前清蛋白(PA)、清蛋白(ALB)、总胆汁酸(TBA)联合检测在肝脏疾病诊断中的应用价值。方法对248例肝病患者(肝炎组32例,肝硬化组43例,肝癌组173例)和68例健康体检者(对照组)同时测定血清PA、ALB、TBA等指标水平,比较肝炎组、肝硬化组、肝癌组和对照组各项指标间的差异。结果肝炎组、肝硬化组、肝癌组肝病患者血清PA、ALB水平均显著低于对照组(P<0.01),TBA水平均高于对照组(P<0.05);肝硬化PA、ALB、TBA异常率最高,显著高于肝炎组和肝癌组(P<0.01)。结论联合测定血清PA、ALB、TBA对肝功能损害的早期诊断和预后判断具有重要临床价值。 Objective To explore the application value of combined detection of serum prealbumin(PA),albumin(ALB) and total bile acid(TBA) in diagnosis of liver disease.Methods Simultaneous detections of serum PA,ALB and TBA were conducted in 248 patients with liver diseases(hepatitis group of 32 patients,liver cirrhosis group of 43 patients and liver cancer group of 173 patients) and 68 healthy people undergoing physical examination.Each indicators in hepatitis,liver cirrhosis,liver cancer and control group were compared.Results Levels of serum PA,ALB were lower(P0.01) and TBA were higher(P0.05) in hepatitis,liver cirrhosis and liver cancer group than those in control group.Serum PA,ALB and TBA in liver cirrhosis group demonstrated the highest rates of abnormality,which were significantly higher than those in hepatitis and liver cancer group(P0.01).Conclusion Combined detection of serum PA,ALB and TBA has important clinical value in early diagnosis and prognosis judgment of liver dysfunction.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第34期3455-3456,3459,共3页 Chongqing medicine
关键词 前清蛋白 清蛋白类 胆汁酸类和盐类 肝疾病 prealbumin albumins bile acids and salts liver diseases
  • 相关文献

参考文献10

二级参考文献38

共引文献100

同被引文献55

  • 1张英霞,张云.血清白蛋白的功能及应用[J].海南大学学报(自然科学版),2007,25(3):315-320. 被引量:58
  • 2Persson EC, Quraishi SM, Welzel TM, et al. Risk of liver cancer among US male veterans with cirrhosis, 1969-1996 [J]. Br J Cancer,2012,107(1) :195-200.
  • 3Goldacre MJ,Wotton CJ, Yeates D, et al. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study[J]. Eur J Gastroenterol Hepatol, 2008,20(5) :384-392.
  • 4Hirata K, Maruyama T, Watanabe H, et al. Genetically engineered mannosylated-human serum albumin as a ver- satile carrier for liver-selective therapeutics[J]. J Control Release, 2010,145 ( 1 ) : 9-16.
  • 5Schiff ER, Lee SS,Chao YC, et al. Long-termtreatment with ente- cavir induces reversal of advanced fibrosis or cir-rhosis in patients with chronic hepatits B[J]. Clin Gastroenterol Hepatol, 2011,9 (3) :274-276.
  • 6Tamaki N, Kurosaki M, Tanaka K, et al. Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C[J]. J Viral Hepat,2013,20(1):72-76.
  • 7GowdaS, Desai PB, Hull VV, et al. A review on laboratory liver funetion tests[J]. Pan African Med J, 2009,3(1) : 17.
  • 8Nina K,Andrea C,Roberta M,et al. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reper{usion injury[J]. Biochim Biophys Acta,2011,18(13) : 1323-1332.
  • 9Mao YL, Huang JZ. Commentary on: Aspartate transaminase to platelet ratio index (APRI) :A simple noninvasive index assessing liver fibrosis in patients with chronic liver diseases[J].Hepat Mon, 2011,28(2) :213-214.
  • 10E1-Tayeh SP, Hussein TD,E1-Houseini ME,et al. Sero-logical hiomarkers of hepatocellular carcinoma in Egyptian patients[J]. Dis Markers, 2012,32(4) : 255-263.

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部